ABC Arbitrage SA Invests $4.85 Million in Smith & Nephew plc (NYSE:SNN)

ABC Arbitrage SA bought a new stake in shares of Smith & Nephew plc (NYSE:SNNFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 197,206 shares of the medical equipment provider’s stock, valued at approximately $4,847,000.

A number of other large investors have also recently made changes to their positions in SNN. R Squared Ltd purchased a new position in shares of Smith & Nephew in the 4th quarter valued at $41,000. GAMMA Investing LLC grew its stake in shares of Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after purchasing an additional 718 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock valued at $94,000 after purchasing an additional 1,290 shares in the last quarter. Blue Trust Inc. grew its position in shares of Smith & Nephew by 26.0% in the fourth quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider’s stock valued at $144,000 after purchasing an additional 1,213 shares during the period. Finally, Coerente Capital Management purchased a new stake in Smith & Nephew during the 3rd quarter worth approximately $202,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew Trading Up 0.0 %

Shares of NYSE SNN opened at $25.72 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The stock’s 50-day moving average is $25.02 and its two-hundred day moving average is $27.45. Smith & Nephew plc has a 1-year low of $23.65 and a 1-year high of $31.72.

Wall Street Analysts Forecast Growth

A number of analysts have commented on SNN shares. Berenberg Bank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. StockNews.com lowered Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st.

View Our Latest Analysis on Smith & Nephew

Smith & Nephew Profile

(Free Report)

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

See Also

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNNFree Report).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.